Home›People›Jan Jensen
Jan Jensen

Jan Jensen

Board Member, Trailhead Biosystems at Trailhead Biosystems.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Jul 30, 2026·Suggest an edit

About Jan Jensen

Jan Jensen is a board member, trailhead biosystems at Trailhead Biosystems.

Jan Jensen first appears on SEC filings in 2020.

Experience

This experience comes from Jan Jensen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jan Jensen in the role, so the role may have started earlier or lasted longer.

Trailhead Biosystems Inc. Current
Board Member, Trailhead Biosystems
Member Board of Directors (2015 – Present)
2015 – Present · Beachwood, OH
Human cell products for drug discovery and cell therapy research.
Cleveland Clinic
Diabetes Research Director
2007 – 2020
OH-Alive - a cell therapy innovator platform
Scientific Director
2013 – 2015
Pancreatic Progenitor Project
Program Director
2007 – 2012
University of Colorado Health Sciences Center
Associate Professor
2007
Novo Nordisk A/S
scientist (1997 – 2001)
PhD student (1991 – 1998)
1991 – 2001

Key Colleagues at Startups

The people Jan Jensen works with at each company, as listed on that company's latest Form D.

Trailhead Biosystems Inc. · Form D/A, Jul 30, 2026
HH
Wolfgang Hofmann
Wolfgang Hofmann
Board Member, Trailhead Biosystems
Craig Nemiroff
Craig Nemiroff
Managing Director, MAK Capital
David Llewellyn
David Llewellyn
President and Chief Executive Officer, director
Joshua Snow
Joshua Snow
Chief Commercial Officer
Divya Trivedi
Divya Trivedi
Chief Operating Officer
Michael Kaufman
Michael Kaufman
Chief Executive Officer, MAK Capital and director

Sources

  1. SECTrailhead Biosystems Inc. Form D/A, filed Jul 30, 2026